Author:
Dekkers Susan,Oomen Agnes G.,Bleeker Eric A.J.,Vandebriel Rob J.,Micheletti Christian,Cabellos Joan,Janer Gemma,Fuentes Natalia,Vázquez-Campos Socorro,Borges Teresa,Silva Maria João,Prina-Mello Adriele,Movia Dania,Nesslany Fabrice,Ribeiro Ana R.,Leite Paulo Emílio,Groenewold Monique,Cassee Flemming R.,Sips Adrienne J.A.M.,Dijkzeul Aart,van Teunenbroek Tom,Wijnhoven Susan W.P.
Funder
European Union Seventh Framework Programme
NANoREG
Subject
Toxicology,General Medicine
Reference83 articles.
1. Specific Advice on Exposure Assessment and Hazard/Risk Characterisation for Nanomaterials under REACH;Aitken,2011
2. A critical appraisal of existing concepts for the grouping of nanomaterials;Arts;Regul. Toxicol. Pharmacol.,2014
3. A decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping);Arts;Regul. Toxicol. Pharmacol.,2015
4. Case studies putting the decision-making framework for the grouping and testing of nanomaterials (DF4nanoGrouping) into practice;Arts;Regul. Toxicol. Pharmacol.,2016
5. A physiologically based pharmacokinetic model for ionic silver and silver nanoparticles;Bachler;Int. J. Nanomed.,2013